ARTICLE | Distillery Therapeutics
Therapeutics: An undetermined target
February 26, 2015 8:00 AM UTC
Cell culture studies have identified a 3-(2-naphthyl)-1-(2-ethoxyphenyl)-2-propen-1-one derivative that could help treat hematologic malignancies and have low toxicity against normal hematopoietic cel...